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Abstract
Background: Blood glucose meters are reliable devices for data collection, providing electronic logs of his-
torical data easier to interpret than handwritten logbooks. Automated tools to analyze these data are necessary to
facilitate glucose pattern detection and support treatment adjustment. These tools emerge in a broad variety in a
more or less nonevaluated manner. The aim of this study was to compare eDetecta, a new automated pattern
detection tool, to nonautomated pattern analysis in terms of time investment, data interpretation, and clinical
utility, with the overarching goal to identify early in development and implementation of tool areas of im-
provement and potential safety risks.
Methods: Multicenter web-based evaluation in which 37 endocrinologists were asked to assess glycemic
patterns of 4 real reports (2 continuous subcutaneous insulin infusion [CSII] and 2 multiple daily injection
[MDI]). Endocrinologist and eDetecta analyses were compared on time spent to analyze each report and
agreement on the presence or absence of defined patterns.
Results: eDetecta module markedly reduced the time taken to analyze each case on the basis of the emminens
eConecta reports (CSII: 18 min; MDI: 12.5), compared to the automatic eDetecta analysis. Agreement between
endocrinologists and eDetecta varied depending on the patterns, with high level of agreement in patterns of
glycemic variability. Further analysis of low level of agreement led to identifying areas where algorithms used
could be improved to optimize trend pattern identification.
Conclusion: eDetecta was a useful tool for glycemic pattern detection, helping clinicians to reduce time
required to review emminens eConecta glycemic reports. No safety risks were identified during the study.
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ª Maria José Comellas, et al., 2017; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the
Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly credited.
DIABETES TECHNOLOGY & THERAPEUTICS
Volume 19, Number 11, 2017




HbA1c is the gold standard as a summary of glycemiccontrol, but regular self-monitoring of blood glucose
(SMBG) is the most accessible way to monitor glycemic ex-
cursions. However, to adjust the treatment in an appropriate
way, an accurate interpretation of the patients’ reports is nee-
ded, but it is hindered by the large amount of data generated.
Decision-making based on glycemic data is time-consuming
and many parameters need to be considered. Pattern manage-
ment has been defined as the systematic interpretation of
SMBG data over time to determine whether changes are re-
quired to optimize blood glucose control.1 However, patterns
are not always easy to detect or interpret and on-meter and
web-based tools have been developed to support both patients
and clinicians to better interpret the data collected.2 Emminens
eConecta is a web-based tool that aims at personalized
management of diabetes, where data collected in the devices
can be downloaded and reviewed by healthcare professionals
(HCPs). Clinicians typically review daily data and trend graphs
from the last 4 registered weeks in combination with the
electronic logbook and lists to fully understand and match
glycemic, carbohydrate, and insulin data coming from pumps
and bolus calculators. eDetecta is an emminens eConecta
module developed to perform an automatic detection of gly-
cemic patterns based on glycemic, insulin, and carbohydrate
data; Figure 1 shows the eDetecta dashboard. The eDetecta
module can analyze up to 22 patterns, grouped into 5 blocks:
glycemic variability, hypoglycemia, hyperglycemia, use of the
system, and adherence to treatment.
Definitions of every pattern are clearly specified in the
platform and default values can be easily customized by HCP
to allow a personalized pattern analysis. Default configura-
tion was agreed by consensus among a group of endocri-
nologists and pediatric experts in diabetes.3
eDetecta can analyze data provided by glucose meters,
bolus calculators, and insulin pumps. An easy-to-interpret
dashboard shows if patterns are present (red) or absent
(green).
The aim of this study was to compare time requirements
and agreement in pattern detection between the automated




This multicenter, cross-sectional web-based evaluation
included 37 endocrinologists from Spain and Portugal, with
an average of 17 years of experience in diabetes. Participants
were asked to analyze 4 cases, obtaining a maximum of 145
evaluations; we esteemed it would provide a reasonable
statistical power.
The evaluation was organized in three parts: a preliminary
questionnaire on eDetecta initial experiences (having used
eDetecta in usual clinical practice with at least four patients),
an evaluation of reports of real-life data downloads, and a
final questionnaire on current barriers related to data analysis
in clinical practice.
FIG. 1. eDetecta dashboard.
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In the second part of the evaluation, participants were
asked to analyze the glycemic patterns of four anonymized
reports of real-life patients’ data and complete a question-
naire indicating if the patterns available in eDetecta were
present or not in the cases. The definition of the eDetecta and
all the relevant information needed to perform manual pattern
detection were available. The reports had been previously
obtained from emminens eConecta platform and included
data from two patients using insulin pumps (continuous
subcutaneous insulin infusion [CSII] therapy) and two pa-
tients using a bolus calculator and multiple daily injections
(MDI) to detect different patterns. These reports consisted of
tendency graphs, data lists, as well as digital patient logbooks
from a period of 4 weeks, representing the reports commonly
obtained from the emminens eConecta. Table 1 summarizes
the report content for each selected case and an example of
the reports obtained, corresponding to the CSII case 2
(Supplementary Data; Supplementary Data are available
online at www.liebertpub.com/dia). To minimize any po-
tential bias due to the order in which cases were reviewed, six
sequences of the four reports were generated and every par-
ticipant was randomly assigned to one of them. The access
period to the web-based evaluation lasted 4 weeks.
Time spent by participants to analyze each case and an-
swers on presence or absence of predefined patterns were
recorded. The clear definition of every pattern was available
in the questionnaire.
Data collection
Total time spent per participant to analyze every report
consisted of two separate times: (1) time needed to read the
report and (2) time needed to evaluate the presence or absence
of patterns and answer the corresponding questions. Time
spent by eDetecta on the automated analysis for each one of the
four reports was also registered. All times were measured in
minutes. Participant responses on the presence of patterns were
compared with automated detected patterns by eDetecta. The
questionnaire on current barriers related to data analysis in
clinical practice included a total number of 30 questions, most
of which were based on a 5-point score Likert-type scale (i.e.,
1 is ‘‘not reliable at all’’ and 5 is ‘‘very reliable’’).
Statistical analysis
The level of agreement in pattern detection between HCPs
and eDetecta was evaluated using Cohen’s kappa coefficient (j)
and associated 95% confidence intervals (CIs) that were cal-
culated both overall and for each of the four cases. A j value of
0.81–1.00 indicates almost perfect agreement; a kappa coeffi-
cient of £0.2 indicates slight or no agreement. The analysis was
adjusted by sequence case and country.5
The report reading time and patterns evaluation time of the
four emminens eConecta reports by HCP and eDetecta
module were evaluated. The total time spent to analyze each
case (report reading time+pattern evaluation time) was cal-
culated for the four reports, adjusting by sequence case and
country (n, adjusted mean, and 95% CI).
Analysis of opinion questionnaires was conducted by
means of absolute and relative frequencies (n, %) for cate-
gorical variables and Likert-scale type variables, and central
trend measures (n, mean, standard deviation [SD], median,
Q1 and Q3, minimum and maximum, 95% CI, and mode) for
continuous variables. The data analysis was adjusted by se-
quence case and country.
The data analysis for this article was generated using SAS/
STAT software, Version 9.2 of the SAS System for Windows
(Copyright (ª) 2002–2008 by SAS Institute, Inc., Cary, NC).
Results
Participants
Thirty-seven participants answered the questionnaires and
responded on the presence of the patterns; most of the par-
ticipants were women (81.1%), endocrinologists (83.8%),
and pediatricians (16.2%), with a mean time of 17 years of
experience in diabetes and visiting a mean number of 18 CSII
patients and 68 MDI patients.
Physician opinion about the eDetecta module
Regarding their experience using the eDetecta module,
91.9% of the clinicians agreed that eDetecta module recog-
nizes the patterns in a few seconds, 78.3% concurred that it
allows them to make decisions faster, and 72.9% agreed that
it saves time in the clinical evaluation of the patient. 67.5% of
the HCP agreed that the module facilitates a more accurate
identification of the abnormal patterns present in the data
downloaded, and 62.1% agreed that it provides reassurance
regarding the detection of anomalies. 75.7% agreed that the
module allows making more adequate decisions and 70.2%
agreed that it allows to dedicate more time to the patient.
Finally, 59.4% of the participants agreed that the module
recognizes a comprehensive list of patterns (Fig. 2).
Regarding the usefulness of the eDetecta module, physi-
cians think that it is useful in automatic pattern detection.
Table 1. Emminens eConecta Reports Content and Time Recovered for Each of the Four Cases
Used to Evaluate the eDetecta Module
Graphs Lists
Time





Case 1 CSII Half page Half page One page Half page One page 42 7 4
Case 2 CSII Half page Half page One page Half page One page 27 4 2
Case 1 MDI Half page Half page Half page One page 10 6 4
Case 2 MDI Half page Half page Half page One page 8 5 4
aCombined: glycemic, CH, insulin and device data at the same list.
CH, carbohydrate; CSII, continuous subcutaneous insulin infusion; MDI, multiple daily injections.
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94.6% agreed that its color code facilitates the interpretation
of the data; 83.7% agreed that it is useful to compare between
periods of time; 89.1% appreciate having a customizable
configuration for each individual patient; 83.7% appreciate
the visualization of all the patterns at the same time, and
64.8% appreciate the analysis detail, including the data that
generated the alerts (Fig. 3).
97.3% of the participants agreed that, when changes in the
configuration are needed, the available ranges cover the more
frequent clinical situations. 83.7% of the participants agreed
that the default configuration of the different patterns is ap-
plicable to most of the patients.
In their usual practice, 70.3% of the participating physi-
cians kept the default configuration in all the patterns of the
eDetecta module, while 29.7% changed some of them,
mainly hypoglycemia (90.9%) and hyperglycemia (72.7%).
Pregnancy was the main reason to change pattern configu-
ration in all the patterns changed.
Participants were also asked about missed relevant patterns
in the module and the answer was ‘‘no’’ for 89.2% of them.
Analysis of the cases
To evaluate the eDetecta module, each investigator was
asked to analyze the report corresponding to 4 cases; a
maximum of 145 evaluations was obtained. CSII cases 1 and
2 were reviewed by 35 and 36 participants, respectively. All
37 endocrinologists reviewed the 2 cases under MDI therapy.
Time spent to analyze the cases. Mean time spent by
physicians to analyze CSII cases was 17 min for case 1 (95%
CI: 13.3–19.3) and 19 min for case 2 (95% CI: 15.6–22.2).
For the MDI cases, mean time to complete case analysis was
12 min for case 1 (95% CI: 9.0–15.5) and 13 min for case 2
(95% CI: 9.3–15.8).
In contrast, the eDetecta module performed the pattern
analysis automatically.
Global pattern detection. The comparison between the
detection of the 19 patterns by HCP and the new eDetecta
module showed a variable agreement depending on the case
FIG. 2. Physician opinion regarding the experience using the eDetecta module.
FIG. 3. Physician perception of the usefulness of the eDetecta module.
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and existing patterns. Overall, the agreement was high (>65%
of agreement in 16 patterns).
Table 2 provides the glycemic patterns defined by default
in the eDetecta module.
Table 3 illustrates the patterns identified by the eDetecta
module and level of agreement with the physician analysis
(present/absent), both overall and for each individual pattern
across the four cases.
Variability patterns. The overall level of agreement for
the variability patterns was high. Presence/absence of the
individual patterns was identified in agreement with eDetecta
by 95.9% of physicians for SD, 89.7% for low blood glucose
index, and 91.7% for high blood glucose index with j values
ranging from 0.62 to 0.88 (Table 2).
Hypoglycemia patterns. Across all four cases, identifi-
cation of the presence/absence of ‘‘hypoglycemic trend,’’
‘‘overcorrection hypoglycemia,’’ ‘‘hypoglycemia in a de-
fined time block,’’ and ‘‘hypoglycemia associated with a
cartridge change’’ was globally in agreement with eDetecta
by 66.9%, 63.4%, 78.6%, and 97.2%, respectively.
Regarding ‘‘hypoglycemic trend’’ (see Table 1 for pattern
definition), the highest level of agreement was achieved for
the MDI case 1, where 89.2% of the participants identified the
present pattern, and the lowest level of agreement was
achieved in the MDI case 2, where the pattern was not
present, but identified by 27.0% of the clinicians.
For ‘‘hypoglycemia due to overcorrection,’’ the highest
level of agreement was obtained in the CSII case 1 (91.4%),
where the pattern was not present, and the lowest level of
agreement was obtained in the CSII case 2, where the pattern
was present and identified by 33.3% of the clinicians.
In the pattern ‘‘hypoglycemia within a defined time block,’’
agreement ranged from 97.3% for the MDI case 1 to 55.6% for
the CSII case 2, being the pattern present in both cases.
‘‘Hypoglycemia associated with a cartridge change’’ was
the pattern with the highest global agreement, reaching
94.3% in the CSII case 1 and 100% in the CSII case 2, being
the pattern absent in both cases.
Hyperglycemia patterns. With regard to hyperglycemia
patterns, global agreement was 44.1% for ‘‘hyperglycemic
trend,’’ 69.0% for ‘‘cartridge change delay’’ and ‘‘over-
correction hyperglycemia,’’ 74.5% for ‘‘hyperglycemia in
time block,’’ and 80.3% for ‘‘missed bolus.’’
For ‘‘hyperglycemic trend,’’ the highest level of agreement
was observed in the CSII case 2, where 91.7% of the partici-
pants recognized the present pattern, and the lowest level of
agreement was observed in the CSII case 1, where the pattern
was absent, but recognized only by 2.9% of the clinicians.
Regarding ‘‘hyperglycemia due to cartridge change de-
lay,’’ the level of agreement was 60.0% for the CSII case 1
and 77.8% for the CSII case 2. In both cases, the pattern was
not present.
Table 2. Glycemic Patterns Included in the Automated eDetecta Module
Blocks Patterns Pattern definition
Variability Standard deviation >70 mg/dL
Low Blood Glucose Index Moderate or high risk of severe hypoglycemia




Hypoglycemic trend >1 Hypoglycemic event/day on 3 consecutive days
Overcorrection hypoglycemia >25% Hypoglycemic events preceded by a hyperglycemic event
Hypoglycemia in a defined
time block
Before/after breakfast, lunch, evening meal, bedtime, nocturnal
Associated with a cartridge
changea
Hypoglycemia present in >80% of cartridge changes
Hyperglycemia
(>160 mg/dL)
Hyperglycemic trend >2 Hyperglycemias/day for 7 consecutive days
Associated with cartridge
change delaya
Cartridge change delay of >1 day during which the >50%
glycemic values are in the hyperglycemia range
Overcorrection hyperglycemia >25% of detected hyperglycemias (glycemia >200 mg/dL)
are preceded by a hypoglycemia within <3 h
Hyperglycemia in time block Over 7 days, >3 hyperglycemias in the same time block
(preprandial glycemia >150 mg/dL, postprandial
glycemia >180 mg/dL)
Missed bolusa Over 4 weeks, >3 hyperglycemias related to missed bolus
(intake of >20 g of CH unrelated to a hypoglycemia




Use of premarks and postmarks <3 Glycemias/day with preprandial or postprandial
marking on >50% of days
Insulin and CH record <3 Insulin and carbohydrate records per day
Pump stoppeda >2 Stops a day on >50% of days
Cartridge change (every 7 days)a Cartridge change delay in >30% of changes
Treatment
adherence
Frequency of BG tests <4 Measurements/day on 80% of days
BG test before bolusa In >25% of boluses, no glycemia measurement in previous 30 min
Bolus calculator usea The bolus calculator was not used in >25% of the boluses
aContinuous insulin infusion cases only.
BG, blood glucose.




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































For ‘‘hyperglycemia due to overcorrection,’’ the highest
and lowest levels of agreement were observed in the CSII
cases, ranging from 85.7% in the case 1 to 52.8% in the case
2, being the pattern absent in both cases.
For ‘‘hyperglycemia in time block,’’ the highest level of
agreement was found in the CSII case 1, where the pattern
was present and correctly identified by 97.1% of the clini-
cians, and the lowest level of agreement was observed in the
MDI case 1, being the pattern present and identified by only
24.3% of the participants.
In the case of ‘‘hyperglycemia due to missed bolus,’’ the
level of agreement was 74.3% for the CSII case 1 and 86.1%
for the CSII case 2, being the pattern absent in both cases.
Use of system patterns. Global agreement for ‘‘use of
system’’ patterns was moderate for the four patterns included.
Regarding the individual patterns, the level of agreement was
moderate-good in three of the four cases for the ‘‘preprandial
and postprandial marks’’ pattern and in all four cases for the
‘‘insulin and carbohydrate [CH]’’ pattern, it was moderate in
both CSII cases for ‘‘pump stopped,’’ and for ‘‘cartridge
change,’’ it was poor in CSII case 1 and moderate in CSII
case 2.
Treatment adherence patterns. Global agreement was
moderate for all three treatment adherence patterns. Pattern
‘‘frequency of BG tests,’’ which was absent in all four cases,
was identified in agreement with eDetecta by 71.4% of the
physicians for CSII case 1, 69.4% of the physicians for CSII
case 2, 59.5% of the physicians for MDI case 1, and 70.3% of
the physicians for MDI case 2. Level of agreement was
moderate-good for the patterns ‘‘BG test before bolus’’ and
‘‘bolus calculator use’’ with a global agreement of 67.3% and
74.6%, respectively, assessed for the two CSII cases.
Physician opinion about data analysis
Regarding the frequency of use of data review methods,
participating physicians suggested that data management
tools are mainly used to review data in patients with insulin
pumps (84.1%) and bolus calculators (79.2%). In contrast,
these tools are only used in 39.6% of patients using a blood
glucose meter, the manual review of patient logbooks being
the most commonly used method.
When asked about the barriers found in using these tools,
physicians highlighted time spent installing different soft-
ware for different devices as the main difficulty.
They indicated that in clinical practice more time is needed
to review insulin pump data (estimated mean time 20.5 min),
followed by bolus calculator data (mean 14.7 min) and meter
data (mean 11.5 min). In summary, physicians found the
eDetecta module useful for automatic pattern detection. The
majority of physicians (94.6%) indicated that it was a reliable
tool. 83.8% of physicians were generally satisfied with the
module and 89.2% of physicians would recommend emmi-
nens eConecta with the eDetecta module to their colleagues.
Discussion
In this case- and survey-based evaluation of glycemic pat-
tern recognition with the eDetecta module, good level of
agreement was shown between physicians and eDetecta pat-
tern recognition, and physicians reported this tool to be useful,
reliable, and comprehensive for clinical practice. Previous
studies have demonstrated the utility of pattern detection
software in achieving more rapid and accurate pattern detec-
tion compared with nonautomated review of clinical data.6,7
Good level of agreement was shown between physician and
eDetecta pattern recognition for patterns relating to glycemic
variability. In these cases, the eDetecta module could prevent
time spent by physicians on mental calculations to identify
clinically relevant patterns. The module can detect automati-
cally moderate or high ranges of Low Blood Glucose Index and
High Blood Glucose Index, and thresholds for SD and per-
centage coefficient of variation for glucose (% CV, obtained
from the calculation: [SD of glucose/mean glucose] · 100) can
be configured. Having a glycemic variability pattern related to
% CV can facilitate an easy identification of stable or unstable
glycemic status. In a recent study, a relationship between the %
CV and frequency of hypoglycemia was found, which was
significantly greater in subjects who had a CV value >36% than
in those who were below this threshold.8 In the other patterns
(hypoglycemia, hyperglycemia, use of the system, and treat-
ment adherence), low level of agreement was observed in at
least one of the cases, but low level of agreement in the same
pattern was never present for all four cases.
Patterns of particular clinical relevance where the level of
agreement between the eDetecta pattern identification and
clinical opinion was low included the following: ‘‘hypogly-
cemic/hyperglycemic trends,’’ ‘‘overcorrection-associated
hypoglycemia/hyperglycemia,’’ and identification of ‘‘hy-
poglycemic/hyperglycemic patterns within defined time
blocks.’’ A deeper analysis focusing on the results with low
level of agreement was conducted.
One of the main causes of low level of agreement was the
understanding of the provided definition for every pattern. For
example, ‘‘Hypoglycemic Trend’’ was initially defined as
‘‘more than 1 hypoglycemia per day over 3 consecutive days.’’
This definition led to a low level of agreement (j = -0.46) in
MDI case 2, where only 27% of participants considered that
the trend was present. According to participants, ‘‘Hypogly-
cemia Trend’’ definition would be more clinically relevant if
‘‘>1’’ was changed to ‘‘at least 1 or more hypoglycemias per
day over 3 consecutive days,’’ potentially improving agree-
ment. Similarly, when ‘‘Hyperglycemic trend’’ is defined as
‘‘more than 2 hyperglycemias a day for 7 consecutive days,’’ a
low level of agreement is obtained in MDI case 2 (j = -0.78);
the authors suggested to change ‘‘>2’’ for ‘‘2 or more hyper-
glycemias a day for 4 consecutive days,’’ possibly increasing
agreement, since this would have clinical sense.
Pattern definition was reached by consensus of a scientific
committee3 composed by a group of endocrinologists and pe-
diatric experts in diabetes, with the aim to cover most patients
and signal those situations that need attention according to
clinical experience; however, the results showed that some of
the default pattern configurations do not fit with the usual
clinical practice. That is why it is important to highlight that
eDetecta pattern definitions are customizable to adjust the
proper values for every patient or group of patients by the HCPs.
Low level of agreement was also present in patterns where
definitions involved a rate like ‘‘overcorrection hypoglycemia
and hyperglycemia’’ (Table 2). Regarding ‘‘hypoglycemia by
hyperglycemia overcorrection,’’ the low level of agreement
could be explained due to the difficulty in mentally calculating
the 25% of cases preceded by a hyperglycemic event, as
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described in the pattern definition. The same pattern in MDI
case 2 reached a higher percentage of identification because
the ratio between the hypoglycemias and previous hypergly-
cemias was more evident.
When analyzing the low level of agreement in the CSII case
2 for ‘‘hyperglycemia by hypoglycemia overcorrection,’’ the
proposed definition did not completely match the perception of
the clinicians. According to the authors, the definition would
be more clinically relevant if the denominator of the equation
is not the total number of hyperglycemias and the threshold
(glycemia >200 mg/dL) is higher, potentially improving
agreement.
Finally, low level of agreement was also present in cases
where contrasting patterns were present. For example, in MDI
case 1, the level of agreement in the pattern ‘‘Hyperglycemia in
Time Block’’ was low (j= -0.51). In this report, there was a
predominant hypoglycemic context at the same time. For
physicians, ‘‘Hyperglycemia in Time Block’’ was not relevant
in the presence of ‘‘Hypoglycemia in Time Block’’ and there-
fore, the level of agreement with eDetecta was low. However,
eDetecta did actually signal the presence of both patterns.
The use of this type of pattern detection software can also
provide caregivers further information on the use of devices,
which is closely related to therapy adherence and is difficult
to obtain otherwise. Patterns related to the frequency of blood
glucose tests before bolus and the use of bolus calculators had
a good level of agreement and were appreciated by the par-
ticipants. Future studies will show if the automatic tool
eDetecta has a clinical impact in diabetes management.
This evaluation was conducted in a version only for pro-
fessional use. The future availability of a version for patient
use could help the empowerment of the patient, and probably
improve the knowledge of the disease and promote self-care
behaviors in their daily life.9
The results of this research have demonstrated the clinical
utility and acceptability of the eDetecta module to support
physicians in evaluating real-life glucose downloads, both in
terms of time invested and pattern identification. This module
is already in use in different centers in Spain and Portugal;
more ranges in pattern definition will be configured in the
module to include as many patients as possible in the default
values, although the capability to adjust the alerts to the needs
of every patient or group of patients by the clinicians will
remain as one of the features of the module, allowing a per-
sonalized management of the patient with diabetes.
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3. Comellas MJ, Albiñana E, Corcoy R, et al.: Consensus to define
alert values of a pattern detection web based module. Diabetes
Technol Ther 2016;18(Suppl. 1):A1–A140. Presented at 9th
International Conference on Advanced Technologies &
Treatments for Diabetes (ATTD), February 2016, Milan, Italy.
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